JSAM
KMTS

J. Safra Asset Management’s Kestra Medical Technologies KMTS Stock Holding History

J. Safra Asset Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48K Sell
176
-37
-17% -$775 ﹤0.01% 523
2026
Q1 		$4.25K Buy
213
+162
+318% +$3.82K ﹤0.01% 497
2025
Q4 		$1.35K Buy
+51
New +$1.31K ﹤0.01% 610

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

J. Safra Asset Management's KMTS Position: Q2 2026 in Review

J. Safra Asset Management reduced its Kestra Medical Technologies (KMTS) stake by 17% in Q2 2026, selling an estimated $775 and leaving 176 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

J. Safra Asset Management first reported a position in KMTS in Q4 2025 and has held it in 3 quarters since. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • J. Safra Asset Management held 176 shares of Kestra Medical Technologies worth $4.48K as of Q2 2026.
  • J. Safra Asset Management sold 37 Kestra Medical Technologies shares in Q2 2026, an estimated $775.
  • Kestra Medical Technologies made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #523 holding.
  • J. Safra Asset Management first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 3 quarters since.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.